Your browser doesn't support javascript.
loading
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
Ganan-Gomez, Irene; Yang, Hui; Ma, Feiyang; Montalban-Bravo, Guillermo; Thongon, Natthakan; Marchica, Valentina; Richard-Carpentier, Guillaume; Chien, Kelly; Manyam, Ganiraju; Wang, Feng; Alfonso, Ana; Chen, Shuaitong; Class, Caleb; Kanagal-Shamanna, Rashmi; Ingram, Justin P; Ogoti, Yamini; Rose, Ashley; Loghavi, Sanam; Lockyer, Pamela; Cambo, Benedetta; Muftuoglu, Muharrem; Schneider, Sarah; Adema, Vera; McLellan, Michael; Garza, John; Marchesini, Matteo; Giuliani, Nicola; Pellegrini, Matteo; Wang, Jing; Walker, Jason; Li, Ziyi; Takahashi, Koichi; Leverson, Joel D; Bueso-Ramos, Carlos; Andreeff, Michael; Clise-Dwyer, Karen; Garcia-Manero, Guillermo; Colla, Simona.
Afiliación
  • Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ma F; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, USA.
  • Montalban-Bravo G; Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Thongon N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Marchica V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Richard-Carpentier G; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Manyam G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang F; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alfonso A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Class C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kanagal-Shamanna R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ingram JP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ogoti Y; AbbVie Oncology Discovery, Chicago, IL, USA.
  • Rose A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Loghavi S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lockyer P; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cambo B; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Muftuoglu M; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Schneider S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Adema V; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • McLellan M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Garza J; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
  • Marchesini M; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
  • Giuliani N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pellegrini M; Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy.
  • Wang J; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Walker J; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, USA.
  • Li Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Takahashi K; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
  • Leverson JD; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bueso-Ramos C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Andreeff M; AbbVie Oncology Discovery, Chicago, IL, USA.
  • Clise-Dwyer K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Colla S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nat Med ; 28(5): 1097, 2022 May.
Article en En | MEDLINE | ID: mdl-35484266
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos